Towards 3% R&D – Medical manufacturing to propel the economy by Dig Howitt of Cochlear

Australia’s R&D effort is focused around medical technologies and here in our editorial series – Towards 3% R&D – Turbocharging Australia’s Innovation Effort – Dig Howitt of Cochlear outlines the way ahead to support innovation in the sector. Cochlear has long been a pioneer in innovation. It has reshaped hearing technology and made substantial contributions…

Alpha HPA progresses battery metals precursor production

Aluminium chemicals company Alpha HPA has continued to develop its Stage 1, battery materials Precursor Production Facility (PPF) in Gladstone, Queensland. The company told investors that following first small scale commercial production of high purity aluminium nitrate (Al-nitrate) precursors in March, the plant was now in production of high purity aluminas (HPA). The company is…

Towards 3% R&D – intelligent systems for defence innovation by Saeid Navahandi

Today in our editorial series – Towards 3% R&D – Turbocharging Australia’s Innovation Effort – Saeid Nahavandi looks at the role robotic and autonomous systems can play in defence innovation and operations. In line with the complexities of modern warfare, the integration of advanced robotic and autonomous systems (RASs), artificial intelligence (AI), and human-machine collaborative…